Sales decline 69.90% to Rs 45.27 crore
Net loss of Fresenius Kabi Oncology reported to Rs 63.63 crore in the quarter ended December 2013 as against net profit of Rs 48.36 crore during the previous quarter ended December 2012. Sales declined 69.90% to Rs 45.27 crore in the quarter ended December 2013 as against Rs 150.38 crore during the previous quarter ended December 2012. ParticularsQuarter EndedDec. 2013Dec. 2012% Var.Sales45.27150.38 -70 OPM %-81.1440.77 -PBDT-40.4769.04 PL PBT-48.8162.35 PL NP-63.6348.36 PLPowered by Capital Market - Live News